NEW YORK (GenomeWeb News) – Leerink Swann analyst Isaac Ro said in a research report published today that he believes a major acquisition by Thermo Fisher Scientific is "likely in the near term, with possible targets coming in the areas of Bioprocess tools, HPLC, or Diagnostics."

He noted that Thermo's shares have lagged the market recently due to ongoing speculation about a major acquisition for the firm. Ro said that given Thermo's broad distribution channel, the company "could choose any of these areas and recognize material benefits."

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.